» Articles » PMID: 4978880

Pathogenesis of Experimental Cholera. Preparation and Isolation of Choleragen and Choleragenoid

Overview
Journal J Exp Med
Date 1969 Jul 1
PMID 4978880
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

Choleragen, a diarrheagenic protein enterotoxin elaborated by Vibrio cholerae, has been isolated from the supernate of fermenter cultures by steps involving ammonium sulfate precipitation, DEAE cellulose, Sephadex G-75, and Agarose A-5m chromatography. The resulting product appears to be pure according to immunoelectrophoretic, disc electrophoretic, ultracentrifugal, and immunologic criteria. Sephadex gel filtration and membrane filtration studies suggest a molecular size of 61,000. The isolated product is highly active in inducing experimental cholera in infant and adult rabbit models. It also elicits, in small dosage, an increased vascular permeability in skin. These observations indicate that choleragenicity and increased vascular permeability are intimately associated phenomena and may be manifestations of the same basic mechanism. An additional, antigenically identical, protein has also been isolated by the same procedures. The latter substance, termed "choleragenoid", lacks the permeability effect and choleragenicity of the choleragen moiety. Its size (estimated from Sephadex gel filtration at 42,000) is smaller than that of choleragen and it also differs in charge. Choleragenoid may prove useful as a nontoxic immunogen to protect against pathologic effects of V. cholerae infection.

Citing Articles

: a fundamental model system for bacterial genetics and pathogenesis research.

van Kessel J, Camilli A J Bacteriol. 2024; 206(11):e0024824.

PMID: 39405459 PMC: 11580405. DOI: 10.1128/jb.00248-24.


Using for High-Yield Production of Challenging Expression Targets and for Protein Perdeuteration.

Mojica N, Kersten F, Montserrat-Canals M, Huhn Iii G, Tislevoll A, Cordara G Biochemistry. 2024; 63(5):587-598.

PMID: 38359344 PMC: 10919088. DOI: 10.1021/acs.biochem.3c00612.


Using for high-yield production of challenging expression targets and for protein deuteration.

Mojica N, Kersten F, Montserrat-Canals M, Huhn 3rd G, Tislevoll A, Cordara G bioRxiv. 2023; .

PMID: 37961550 PMC: 10635113. DOI: 10.1101/2023.11.03.565449.


Beyond protein modification: the rise of non-canonical ADP-ribosylation.

Schuller M, Ahel I Biochem J. 2022; 479(4):463-477.

PMID: 35175282 PMC: 8883491. DOI: 10.1042/BCJ20210280.


Upregulation of virulence genes promotes biofilm hyperinfectivity.

Gallego-Hernandez A, DePas W, Park J, Teschler J, Hartmann R, Jeckel H Proc Natl Acad Sci U S A. 2020; 117(20):11010-11017.

PMID: 32355001 PMC: 7245069. DOI: 10.1073/pnas.1916571117.


References
1.
BENYAJATI C . Experimental cholera in humans. Br Med J. 1966; 1(5480):140-2. PMC: 1843319. DOI: 10.1136/bmj.1.5480.140. View

2.
Andrews P . The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J. 1965; 96(3):595-606. PMC: 1207193. DOI: 10.1042/bj0960595. View

3.
Finkelstein R, Atthasampunna P, Chulasamaya M, Charunmethee P . Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A. J Immunol. 1966; 96(3):440-9. View

4.
Craig J . A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera. Nature. 1965; 207(997):614-6. DOI: 10.1038/207614a0. View

5.
Finkelstein R, Sobocinski P, Atthasampunna P, Charunmethee P . Pathogenesis of experimental cholera: identification of choleragen (procholeragen A) by disc immunoelectrophoresis and its differentiation from cholera mucinase. J Immunol. 1966; 97(1):25-33. View